Pharvaris (PHVS) Interest Expenses (2020 - 2024)
Pharvaris (PHVS) posted Interest Expenses of -$128.4 billion for Q3 2024, up 50.04% on a QoQ basis from -$257.0 billion in Q4 2023.
Pharvaris (PHVS) Interest Expenses (2020 - 2024) Analysis & Trends
Pharvaris' Interest Expenses history runs 5 years deep, the most recent figure standing at -$128.4 billion for Q3 2024.
- Quarterly Interest Expenses changed N/A year-over-year to -$128.4 billion in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$128.4 billion (down 191289232.56% YoY) and the FY2023 annual result came in at -$258.4 billion, down 624644381.68% from the prior year.
- Interest Expenses was -$128.4 billion for Q3 2024 at Pharvaris, up from -$257.0 billion in the prior quarter.
- Across five years, Interest Expenses topped out at $297037.2 in Q2 2021 and bottomed at -$257.0 billion in Q4 2023.
- A 5-year average of -$32.1 billion and a median of $6801.0 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2021 — Interest Expenses soared 535.92% — and 2023, when it tumbled 382873551.54%.
- Pharvaris' Interest Expenses stood at $46709.6 in 2020, then declined by 28.12% to $33574.4 in 2021, then plunged by 299.96% to -$67136.4 in 2022, then tumbled by 382873551.54% to -$257.0 billion in 2023, then surged by 50.04% to -$128.4 billion in 2024.
- Business Quant data shows PHVS's Interest Expenses at -$128.4 billion in Q3 2024, -$257.0 billion in Q4 2023, and -$67136.4 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Pharvaris | 2.17 Bn | 1.88 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -128.42 Bn |
| Sep 30, 2024 | -128.42 Bn |
| Dec 31, 2023 | -257.05 Bn |
| Dec 31, 2023 | -257.05 Bn |
| Dec 31, 2022 | -67,136.36 |
| Dec 31, 2022 | -67,136.36 |
| Sep 30, 2022 | 26,257.48 |
| Sep 30, 2022 | 26,257.48 |
| Jun 30, 2022 | 137,810.37 |
| Jun 30, 2022 | 137,810.37 |
| Mar 31, 2022 | -56,267.28 |
| Mar 31, 2022 | -56,267.28 |
| Dec 31, 2021 | 33,574.40 |
| Dec 31, 2021 | 33,574.40 |
| Sep 30, 2021 | 92,854.73 |
| Sep 30, 2021 | 92,854.73 |
| Jun 30, 2021 | 297,037.16 |
| Jun 30, 2021 | 297,037.16 |
| Mar 31, 2021 | -104,990.79 |
| Mar 31, 2021 | -104,990.79 |